Next-generation chimeric antigen receptor platforms for skin cancer immunotherapy: Biological rationale, therapeutic opportunities, and precision selection strategies.
- DOI
- 10.1016/j.ctarc.2026.101512
- Published
- 2026 Oct 29
- Container
- Cancer treatment and research communications
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctarc.2026.101512,
title = {Next-generation chimeric antigen receptor platforms for skin cancer immunotherapy: Biological rationale, therapeutic opportunities, and precision selection strategies.},
author = {Sayed U and Rizaev J and Polatova D and Abdulqader AF and Jbar RM and Maharana L and Singhal D and Tailor NK},
year = {2026},
journal = {Cancer treatment and research communications},
doi = {10.1016/j.ctarc.2026.101512},
url = {https://doi.org/10.1016/j.ctarc.2026.101512}
}RIS
TY - JOUR TI - Next-generation chimeric antigen receptor platforms for skin cancer immunotherapy: Biological rationale, therapeutic opportunities, and precision selection strategies. AU - Sayed U AU - Rizaev J AU - Polatova D AU - Abdulqader AF AU - Jbar RM AU - Maharana L AU - Singhal D AU - Tailor NK PY - 2026 JO - Cancer treatment and research communications DO - 10.1016/j.ctarc.2026.101512 UR - https://doi.org/10.1016/j.ctarc.2026.101512 ER -
APA
U, S., J, R., D, P., AF, A., RM, J., L, M., D, S., & NK, T. (2026). Next-generation chimeric antigen receptor platforms for skin cancer immunotherapy: Biological rationale, therapeutic opportunities, and precision selection strategies.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101512
Source records
- pubmed · retrieved 2026-11-10T10:58:54.539Z